This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
ASCO 2024
All Conferences
View All
PCF
UroToday Home
Beyond the Abstracts
Urologic Oncology
Prostate Cancer
Beyond the Abstracts
Reclassification rates are higher among African American men than Caucasians on active surveillance, "Beyond the Abstract," by Debasish Sundi, MD and Edward M. Schaeffer, MD, PhD
May 1, 2015
Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer, "Beyond the Abstract," by Tom S. Feng, MD
May 1, 2015
A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer, "Beyond the Abstract," by Neha Vapiwala, MD
April 29, 2015
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer, "Beyond the Abstract," by Nicole White-Al Habeeb and Bharati Bapat
April 28, 2015
Evolving patterns of metastatic castration-resistant prostate cancer, "Beyond the Abstract," by William K. Oh, MD, et al
April 23, 2015
A phase I study of TRC105 anti-CD105 (endoglin) antibody in metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Fatima Karzai, Ravi A. Madan, and William L. Dahut
April 21, 2015
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer, "Beyond the Abstract," by Mary-Ellen Taplin, MD and Philip Kantoff, MD
April 20, 2015
Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy, "Beyond the Abstract," by Daniel E. Spratt and Michael J. Zelefsky
April 17, 2015
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy, "Beyond the Abstract," by Wan Song and Hwang Gyun Jeon
April 17, 2015
Is prostate cancer prophylaxis with dietary supplements more than just an illusion? "Beyond the Abstract," by Walter Merkle
April 15, 2015
A literature review seeking evidence of resistance to abiraterone in castration-resistant prostate cancer, "Beyond the Abstract," by Silvana Giacinti
April 14, 2015
Management of the adverse effects of androgen deprivation therapy in prostate cancer, "Beyond the Abstract," by Handoo Rhee and Ian Vela
April 8, 2015
Is a 12-core biopsy still necessary, in addition to a targeted biopsy, in patients with a previous negative prostate biopsy and a suspicious lesion on MRI? "Beyond the Abstract," by Art R. Rastinehad, DO
April 2, 2015
Advanced prostate cancer - patient survival and potential impact of enzalutamide and other emerging therapies, "Beyond the Abstract," by Nihar K. Patel, MD and Jeanny B. Aragon-Ching, MD
April 2, 2015
High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients, "Beyond the Abstract," by Yasuhide Miyoshi, MD, PhD
March 26, 2015
DuraSeal® as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer, "Beyond the Abstract," by Markku H. Vaarala
March 20, 2015
Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score, "Beyond the Abstract," by Xu-Dong Yao and Yue Wang
March 20, 2015
An 8-year longitudinal study of Japanese men and long-term quality of life after radical prostatectomy, "Beyond the Abstract," by Shunichi Namiki, MD
March 19, 2015
A prospective randomized trial using a combination of lidocaine suppository and periprostatic nerve block during transrectal prostate biopsy, "Beyond the Abstract," by Andreas Lunacek, MD, et al
March 18, 2015
Image-guided focal therapy for prostate cancer, "Beyond the Abstract," by Sandeep Sankineni, MD and Baris Turkbey, MD
March 13, 2015
Page 34 of 57
Start
Prev
29
30
31
32
33
34
35
36
37
38
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free